MedPath
NMPA Approval

Desloratadine for Suspension

国药准字H20041111

September 15, 2020

Drug Information

地氯雷他定干混悬剂

芙必叮

芙必叮

口服混悬剂

0.5g:2.5mg

化学药品

September 15, 2020

Company Information

Applicant Company

海口市美兰区桂林洋经济开发区

Manufacturing Company

海南普利制药股份有限公司;浙江普利药业有限公司

海口市美兰区桂林洋经济开发区;浙江省杭州市临平区经济开发区新洲路78号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

地氯雷他定干混悬剂 - NMPA 批准文号 | MedPath